Funds and prices
Overview
Regulation / Supervision: UCITS III / CSSF (funds for institutional investors)
Authorised investors: pension funds, insurance companies, family offices and institutional investors under CISA
Investments: Equity securities issued by European companies listed in the MSCI Europe ex UK ex Switzerland Index
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
Convertible and warrant bonds: none
Portfolio is passively managed and aims to replicate the performance of the benchmark
Currency exposure: in line with securities portfolio
Securities lending: permitted
Use of derivatives: permitted under BVV2
The exchange rate risk between CHF and EUR is not hedged.
Risks
All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.
Features
| Product category |
Equity
Global |
| Product domicile |
Luxembourg
|
| Portfolio management |
蜜豆视频 Asset Management Switzerland AG, Zurich
|
| Fund management |
蜜豆视频 Fund Management (Luxembourg) S.A., Luxembourg
|
| Custodian bank |
蜜豆视频 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
蜜豆视频 Fund Management (Switzerland) AG
|
| Day of inception |
October 21, 2021
|
| Currency of account |
EUR
|
| Close of financial year |
December 31
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Flat fee |
0.00% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.02% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex UK ex Switzerland (net div. reinv.) in EUR
|
| Cut-Off Time |
15:00h (CET)
|
| Securities no. |
110184535
|
| ISIN |
LU2308697585
|
| Bloomberg Ticker |
UBESPXE LX
|
Performance and Prices
Percentage growth
as of April 3, 2024
Cumulative
| EUR(%) | CHF(%) | USD(%) | |
| YTD | 9.93 | 15.92 | 7.70 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 26.30 | 21.14 | 23.85 |
| 3Y | |||
| 5Y | |||
| ø p.a.5Y | 12.38 | 10.06 | 11.29 |
Current data
| Net asset value | 03.04.2024 | EUR 1,190.42 |
| High - last 12 months | 27.03.2024 | EUR 1,194.14 |
| Low - last 12 months | 27.10.2023 | EUR 955.93 |
| Assets of the unit class in mn | 03.04.2024 | EUR 69.39 |
| Total product assets in mn | 03.04.2024 | EUR 929.65 |
Statistical data
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 29.02.2024 | 16.88% | n.a. |
| Sharpe Ratio | 29.02.2024 | 0.51 | n.a. |
| Risk Free Rate | 31.03.2024 | 2.23% | 0.61% |
Structures
By the 10 largest equity positions (in %, as of February 29, 2024)
|
|
|
| Novo Nordisk A/S | 5.74 |
| ASML Holding NV | 5.56 |
| LVMH Moet Hennessy Louis Vuitton SE | 3.69 |
| SAP SE | 2.87 |
| Siemens AG | 2.21 |
| TotalEnergies SE | 2.14 |
| Schneider Electric SE | 1.81 |
| L'Oreal SA | 1.69 |
| Allianz SE | 1.61 |
| Sanofi SA | 1.59 |
Fees
Portfolio management fees
0.0000%
Admin/Custodian fees, max.
0.0000%
Distributions
No distributions. Continuous reinvestment of income.
Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
||
| Swiss Climate Scores Report |
|
|||
| ASIP ESG Report |
|
|
|
Annual and semi-annual report (accounting on December 31)
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| Semi-annual report |
|
|
|
